Skip to main content
230811-Rev-A-LBS-Homepage-Hero-Video-2023-720p-thumb

InnovationCodes Our DNA

150+ years tackling pathology challenges head on, from better slide production to world-leading Digital Pathology empowering AI development. Our passionate experts drive our mission of Advancing Cancer Diagnostics, Improving Lives.

Alternative text hereAlternative text here

Aperio GT 450 DX - Proven Digital Pathology for Diagnostic Excellence!

Exceed your expectations with our 25 years of scanner technology innovations and expertise, including a dedicated, in-house team of application and field engineers, to help ensure your investment is safeguarded and guides you towards Diagnostic Excellence.

LEARN MORE

Integrated Solutions. Proven Performance. Reliable Results.

Customer Perspectives

Image
Dr.-Eric-Peltier-260x440-2

“Thanks to our partnership with Leica, we have access to instruments of the highest caliber. The whole approach is about the quality, traceability, and connectivity…It's a base to work on innovation and development relying on the know-how of the pathologist. We also want to develop other technologies associated with this basis. So, it can be digital pathology technologies based on artificial intelligence.”

Translated from source language.

Dr. Eric Peltier
Président Directeur Général - PRAXEA-DIAGNOSTICS

Image
Dr-Sylvia-L-Asa-MD-PhD-260x440

"Leica Biosystems products are reliable and high quality, and the company is realistic about what's required to transform traditional pathology to a digital, connected practice. I know I can count on them and trust they will be there to support me now and well into the future."

Translated from source language.

Dr. Sylvia L. Asa, MD, PhD
Consultant in Endocrine Pathology, University Hospitals Cleveland Medical Center

News & Promotions

Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM

Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due to the COVID-19 pandemic, Aperio GT 450 DX is proven technology that consistently delivers high-quality images at a fast turnaround time of < 32 sec/slide.

Press Release

Enjoy the speed and convenience of online ordering

Purchase Using our Online Store

Online prices are available for over 1,000 consumable products

View our Online Store

Limited Time Offer

Trade in Your Microtome for A New Microtome!

Trade In Your Current Microtome for A New Leica Biosystems Rotary Microtome. Now is your chance to trade in your current microtome and trade up to a new Leica Biosystems state-of-the-art microtome! Terms & conditions apply.

Get My Trade In Offer